Psychopharmacology and Psychiatry Updates
Podcast tekijän mukaan Psychopharmacology Institute
Kategoriat:
213 Jaksot
-
Neurocovid: Pharmacologic Recommendations for Delirium Associated With COVID-19
Julkaistiin: 29.9.2021 -
How to Assess Psychotropic Drug Adherence
Julkaistiin: 24.9.2021 -
Citalopram for Acute and Preventive Efficacy in Bipolar Depression (CAPE-BD)
Julkaistiin: 19.9.2021 -
Delirium, Catatonia, and COVID-19
Julkaistiin: 14.9.2021 -
Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder
Julkaistiin: 9.9.2021 -
Dopamine and Depression: Clinical Considerations
Julkaistiin: 4.9.2021 -
Haloperidol, Chlorpromazine, and Atypical Antipsychotics for Managing Delirium
Julkaistiin: 30.8.2021 -
New Somatic Treatments for Child and Adolescent Depression
Julkaistiin: 25.8.2021 -
Management of Delirium: Nonpharmacologic Strategies
Julkaistiin: 20.8.2021 -
Emerging Complementary and Integrative Therapies for Geriatric Mental Health
Julkaistiin: 15.8.2021 -
Delirium: Assessment, Consequences, and Sequelae
Julkaistiin: 10.8.2021 -
In Search of a Dose-Response Relationship in SSRIs
Julkaistiin: 5.8.2021 -
Valproate/Divalproex: Metabolism, Kinetics, and Warnings
Julkaistiin: 31.7.2021
Practical psychopharmacology updates for mental health clinicians. Useful for psychiatry / mental health professionals. Expert interviews and soundbites from CME presentations. Practical and free of commercial bias. Not sponsored by any pharmaceutical company.
